These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 308708)

  • 1. [State of the immunity and treatment of amyloidosis].
    Kuznetsova OP; Khasabov NN
    Ter Arkh; 1978; 50(8):143-8. PubMed ID: 308708
    [No Abstract]   [Full Text] [Related]  

  • 2. [State of humoral and cellular immunity in experimental amyloidosis].
    Eganian GA; Kuznetsova OP
    Arkh Patol; 1977; 39(4):44-50. PubMed ID: 327984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular aspects of amyloid disease: present status.
    Scheinberg MA; Wohlgethan JR; Cathcart ES
    Prog Allergy; 1980; 27():250-76. PubMed ID: 6766217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathogenesis of amyloidosis in periodic disease].
    Aĭvazian AA; Giulikekhvian NG; Zavgorodniaia AM; Abramian MK; Pashinian SA
    Klin Med (Mosk); 1982 Jan; 60(1):65-8. PubMed ID: 6978969
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of various immunity factors in the pathogenesis of lactation mastitis].
    Fishchenko AIa; Zhuchenko AP
    Khirurgiia (Mosk); 1984 Jun; (6):42-5. PubMed ID: 6611444
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells.
    Hard RC
    Clin Exp Immunol; 1975 Nov; 22(2):330-40. PubMed ID: 1082403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
    Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
    J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune response in hepatic cirrhosis: animal and human studies.
    Thomas HC
    Proc R Soc Med; 1977 Aug; 70(8):521-5. PubMed ID: 303362
    [No Abstract]   [Full Text] [Related]  

  • 9. Casein-induced experimental amyloidosis. III. Response to mitogens, allogeneic cells, and graft-versus-host reactions in the murine model.
    Scheinberg MA; Cathcart ES
    Immunology; 1974 Nov; 27(5):953-63. PubMed ID: 4154917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiological studies of amyloidosis--introduction of disease models and immunogenetic analysis].
    Miyamoto H; Matsuo T; Haraguchi S; Mizuno M; Yoshida TO; Shreffler DC
    Nihon Rinsho; 1979 Sep; 37(9):3231-44. PubMed ID: 392143
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic dysfunction and interstitial pulmonary fibrosis].
    Belokrinitskiĭ DV; Kudriavitskiĭ AI; Kornev BM; Ovchinnikov AA; Shatalov NN
    Vestn Akad Med Nauk SSSR; 1985; (11):27-32. PubMed ID: 3879058
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis of amyloidosis].
    Mukhin NA; Vinogradova OM; Serov VV; Sura VV; Khasabov NN
    Ter Arkh; 1979; 51(10):33-7. PubMed ID: 505278
    [No Abstract]   [Full Text] [Related]  

  • 13. [The current procedures in the treatment of amyloidosis].
    Vinogradova OM; Kochubeĭ LN; Chegaeva TV
    Ter Arkh; 1990; 62(6):139-45. PubMed ID: 2218913
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of heterospecific antiserum against lymph node cells on the development of experimental amyloidosis in mice.
    Ranlov P
    Acta Pathol Microbiol Scand; 1967; 69(4):534-42. PubMed ID: 6031367
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune system and the immunological reactivity of the body].
    Petrov RV
    Vopr Okhr Materin Det; 1976 Nov; 21(11):3-14. PubMed ID: 795152
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental murine amyloidosis: a model system for studying amyloid formation.
    Baumal R; Wilson B; Pass E
    Can Med Assoc J; 1975 Sep; 113(6):512-6. PubMed ID: 1080430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-laboratory indicators in the prognosis and treatment of chronic obstructive bronchitis].
    Kaznacheeva EI; Aksenova NV; Razin AS; Igonina NP; Popkova AM
    Sov Med; 1989; (9):78-81. PubMed ID: 2603041
    [No Abstract]   [Full Text] [Related]  

  • 18. [Septic endocarditis--a predictable or unpredictable disease? Clinico-immunologic aspects].
    Gogin EE; Tiurin VP
    Ter Arkh; 1986; 58(3):92-6. PubMed ID: 3487129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental murine amyloid. IV. Amyloidosis and immunoglobulins.
    Willerson JT; Asofsky R; Barth WF
    J Immunol; 1969 Oct; 103(4):741-9. PubMed ID: 4186916
    [No Abstract]   [Full Text] [Related]  

  • 20. Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.
    Ishizaka K; Adachi T
    J Immunol; 1976 Jul; 117(1):40-7. PubMed ID: 1084370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.